Artivion News

Stifel: Maintaining the Artivion (AORT.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $22.00 to $25.00.

Zhitong FinanceMay 7 07:50

Oppenheimer Sticks to Its Buy Rating for Artivion (AORT)

TipRanksMay 7 07:17

Artivion: Strong Q1 Performance and Raised Guidance Validate Buy Rating

TipRanksMay 7 06:38

Artivion Analyst Ratings

BenzingaMay 7 04:54

Needham Maintains Buy on Artivion, Raises Price Target to $30

BenzingaMay 7 04:55

Needham: Maintaining the Artivion (AORT.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $25.00 to $25.00.

Zhitong FinanceApr 8 13:40

Artivion Analyst Ratings

BenzingaApr 8 13:34

Artivion's Growth Trajectory: A Buy Rating Amidst Promising Aortic Products and Financial Upswing

TipRanksApr 8 13:15

Stifel Nicolaus Remains a Buy on Artivion (AORT)

TipRanksFeb 16 07:08

Oppenheimer Sticks to Its Buy Rating for Artivion (AORT)

TipRanksFeb 16 06:56

Artivion Secures Buy Rating: Strong Financials and Growth Trajectory Propel Price Target Increase

TipRanksFeb 16 04:56

Needham Maintains Buy on Artivion, Raises Price Target to $25

BenzingaFeb 16 04:44

Artivion Analyst Ratings

BenzingaFeb 16 04:43

Buy Rating on Artivion's Stock Backed by Strong PERSEVERE Study Results and Market Potential

TipRanksJan 30 09:16

Analysts Conflicted on These Healthcare Names: Pfizer (PFE), Artivion (AORT) and Apollo Medical Holdings (AMEH)

TipRanksJan 30 07:50

Lake Street Keeps Their Buy Rating on Artivion (AORT)

TipRanksJan 22 13:24

Artivion (AORT) Gets a Buy From Stifel Nicolaus

TipRanksJan 22 13:23

Needham Reiterates Buy on Artivion, Maintains $22 Price Target

BenzingaDec 7, 2023 04:47

Artivion Analyst Ratings

BenzingaDec 7, 2023 04:45

Oppenheimer Sticks to Their Buy Rating for Artivion (AORT)

TipRanksNov 3, 2023 07:14